Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 13,819 | 14,446 | 13,015 | 12,807 | 10,003 |
| Cost of Goods | 4,017 | 3,469 | 5,836 | 4,506 | 4,561 |
| Gross Profit | 9,802 | 10,977 | 7,179 | 8,301 | 5,442 |
| Operating Expenses | 18,042 | 15,650 | 36,854 | 20,286 | 17,371 |
| Operating Income | -8,223 | -4,204 | -28,839 | -11,479 | -11,368 |
| Interest Expense | 3,840 | 3,936 | 4,273 | 4,273 | 4,276 |
| Other Income | -10,801 | 83 | 1,252 | 306 | 2,096 |
| Pre-tax Income | -22,864 | -8,057 | -31,860 | -15,446 | -13,548 |
| Net Income Continuous | -22,864 | -8,057 | -31,860 | -15,446 | -13,548 |
| Net Income | $-22,864 | $-8,057 | $-31,860 | $-15,446 | $-13,548 |
| EPS Basic Total Ops | -0.18 | -0.07 | -0.26 | -0.14 | -0.14 |
| EPS Basic Continuous Ops | -0.18 | -0.07 | -0.27 | -0.14 | -0.14 |
| EPS Diluted Total Ops | -0.18 | -0.07 | -0.26 | -0.14 | -0.14 |
| EPS Diluted Continuous Ops | -0.18 | -0.07 | -0.27 | -0.14 | -0.14 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | -0.26 | -0.14 | -0.14 |
| EBITDA(a) | $-6,320 | $-1,805 | $-25,960 | $-8,592 | $-8,480 |